The CTC collaborates with the Australasian Lung Cancer Trials Group (ALTG) to facilitate high quality clinical research in Australia and New Zealand.

In recent years, the partnership has expanded into new trials looking at immunotherapy and targeted therapies for lung cancers, as well as renewed interest in mesothelioma, and most recently expanding into genomic profiling to deliver personalised precision medicine.

 

  

 

Lung Cancers